| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES |
Active Substance:Tacrolimus Monohydrate |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: purification by column chromatography, extraction with solvent, recrystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Sirolimus |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Filtration, preparative HPLC, recrystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Cyclosporin |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Column Chromatography, Carbon Treatment, Crystallisation, Filtration, Milling, Sifting
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Mycophenolate Mofetil |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Activated Carbon Treatment, Filtration, Crystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Mycophenolate Sodium |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Activated Carbon Treatment, Filtration, Crystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Temsirolimus |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Filtration, Crystallistion
|
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Everolimus or Everolimus with 2 % BHT |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Chromatography, Decolorisation with active carbon, if need be 2% BHT, Crystallisation
|
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Romidepsin |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Filtration, Crystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Mupirocin |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Activated Carbon Treatment, Filtration, Crystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Mupirocin Calcium |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Filtration, Crystallisation
|
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Activated Carbon Treatment, Filtration, Crystallisation
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Pimecrolimus |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Crystallisation, Filtration
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Mitomycin |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Crystallisation, Filtration
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Fidaxomixin |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Crystallisation, Filtration
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|
Active Substance:Dactinomycin |
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: Extraction with solvent, filtration, crystallisation, purification by column chromatography
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:Midostaurin |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: Filtration, Crystallisation, Decolorisation with active carbon, Filtration, recrystallisation
|
|
|
3.3
|
Manufacturing of Active Substance using Biological Processes
|
| |
| 3.3.1 Fermentation |
| 3.3.3 Isolation / Purification |
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
| 3.6.2 Microbiological testing excluding sterility testing |
|